Project Number 5R01AG047146-05 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Treatment of psychosis and agitation in Alzheimers disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia a. Pharmacological Researcher and Organization Principal Investigator DEVANAND, DAVANGERE P Principal Investigator First Name DAVANGERE P Principal Investigator Last Name DEVANAND Awardee Organization NEW YORK STATE PSYCHIATRIC INSTITUTE Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-11-100: Alzheimer's Disease Pilot Clinical Trials (R01) FY Overall Cost $576,550 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Treatment of Psychosis and Agitation in Alzheimer's Disease
